Factors affecting banking quality of umbilical cord blood for transplantation
Hongyou Yang
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorMona R. Loutfy
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorStephanie Mayerhofer
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorPaul Shuen
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorHongyou Yang
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorMona R. Loutfy
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorStephanie Mayerhofer
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorPaul Shuen
From the Progenics Cord Blood Cryobank and Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Search for more papers by this authorAbstract
BACKGROUND: The most important objective for cord blood banks is to store cord blood units of high quality, which is determined by total nucleated cells (TNCs) and CD34+ cells. Determining the factors affecting the stored life-saving cells would be beneficial to the field.
STUDY DESIGN AND METHODS: A total of 4930 cord blood units were collected between January 2007 and October 2009 and processed using a double extraction technique to sediment red blood cells with variable centrifugation time determined by the formula CT = KL – M, where CT is centrifuge time, K is 7.7227, M is 29.742, and L is ln (volume of cord blood with anticoagulant). The recovery rate of TNCs and other relevant factors affecting banking quality were analyzed.
RESULTS: The mean recovery rate of TNCs was 97.7 ± 2.5% with 0.04% (2/4930) units below 80% and 10.8% (532/4930) units below 95%. The TNCs per unit was affected by gestation duration (p < 0.01), sex of infant (p < 0.01), mode of delivery (p < 0.01), collection method (p < 0.01), and ethnicity (p < 0.001). The number of postprocessing CD34+ cells was affected only by sex of the infant (p < 0.05). The viability of nucleated cells after processing was 94.8 ± 4.8% and was affected by the number of hours between collection and processing (p < 0.01). In contrast, the viability of CD34+ cells was 99.5 ± 1.0% (n = 30) when samples with low viability of TNCs were assessed. The results did not reveal a significant correlation (r = 0.07, p = 0.38).
CONCLUSION: The double extraction technique provides a high and consistent recovery of TNCs, which ensures that more life-saving cells will be banked for transplants.
REFERENCES
- 1 Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
- 2 Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-54.
- 3 Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, Kapoor N, Guinan EC, Feig SA, Wagner EL, Kernan NA, COBLT Steering Committee. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008; 112: 4318-27.
- 4 Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, Takahashi TA, Ortega J, Filipovich A, Locatelli F, Asano S, Fagioli F, Vowels M, Sirvent A, Laporte JP, Tiedemann K, Amadori S, Abecassis M, Bordigoni P, Diez B, Shaw PJ, Vora A, Caniglia M, Garnier F, Chevret S, et al. Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
- 5 Rocha V, Cornish J, Sievers EL, Flipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Gluckman E. et al. Comparisons of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukaemia. Blood 2001; 97: 2962-71.
- 6 Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
- 7 Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-8.
- 8 Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-9.
- 9 Kurtzberg J, Cairo MS, Fraser JK, Baxter-Lowe L, Cohen G, Carter SL, Kernan NA. Results of the cord blood transplantation (COBLT) study unrelated donor banking program. Transfusion 2005; 45: 842-55.
- 10 Lasky LA, Lane TA, Miller JP, Lindgren B, Patterson HA, Haley NR, Ballen K. In utero or ex utero cord blood collection: which is better? Transfusion 2002; 42: 1261-7.
- 11 Solves P, Moraga R, Saucedo E, Perales A, Soler MA, Larrea L, Mirabet V, Planelles D, Carbonell-uberos F, Monleón J, Planells T, Guillén M, Andrés A, Franco E. Comparison between two strategies for umbilical cord blood collection. Bone Marrow Transplant 2003; 31: 269-73.
- 12 Solves P, Mirabet V, Blanquer A, Delgado-Rosas F, Planelles D, Andrade M, Carbonell-Uberos F, Soler MA, Roig R. A new automatic device for routine cord blood banking: critical analysis of different volume reduction methodologies. Cytotherapy 2009; 11: 1101-7.
- 13 Yang H, Acker JP, Abley D, McGann LE, Akabutu J. High-efficiency volume reduction of cord blood using pentastarch. Bone Marrow Transplant 2001; 27: 457-61.
- 14 Rubinstein P, Dobrila L, Richard E, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119-22.
- 15 Yang H, Acker JP, Cabuhat M, Letcher B, Larratt L, McGann LE. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Bone Marrow Transplant 2005; 35: 881-7.
- 16 Van Haute I, Lootens N, De Smet S, Verdegem L, Vanheusden K, Pinxteren J, Vandekerckhove B. Viable CD34+ cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion 2004; 44: 547-54.
- 17
Keeney M,
Chin-Yee I,
Weir K,
Popma J,
Nayar R,
Sutherland DR.
Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines.
Cytometry
1998; 34: 61-70.
10.1002/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 18 Smith FO, Thomson BG. Umbilical cord blood collection, banking, and transplantation: current status and issues relevant to perinatal caregivers. Birth 2000; 27: 127-35.
- 19 Moroff G, Eichler H, Brand A, Kekomäki R, Kurtz J, Letowska M, Pamphilon D, Read EJ, Porretti L, Lecchi L, Reems JA, Sacher R, Seetharaman S, Takahashi TA, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006; 46: 507-15.
- 20 Brand A, Eichler H, Zbigniew M, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de Watering LM, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise. Transfusion 2008; 48: 546-9.
- 21 Flores AI, McKenna D, Montalban MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion 2009; 49: 636-47.
- 22 Lecchi L, Perego L, Garcea F, Ratti I, Brasca M, Dotti D, Cimoni S, Pezzali I, Celeste T, Giovanelli S, Butti B, De Fazio N, Lopa R, Rebulla P. Ten-year quality control of a semiautomated procedure of cord blood unit volume reduction. Transfusion 2009; 49: 563-9.
- 23 Nakagawa R, Watanabe T, Kawano Y, Kanai S, Suzuya H, Kaneko M, Watanabe H, Okamoto Y, Kuroda Y, Nakayama T, Chugoku-Shikoku Cord Blood Bank. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion 2004; 44: 262-7.
- 24 Lapierre V, Pellegrini N, Bardey I, Malugani C, Saas P, Garnache F, Racadot E, Schillinger F, Maddens S. Cord blood volume reduction using automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyel starch sedimentation) for routine cord blood banking: a comparative study. Cytotherapy 2007; 9: 165-9.
- 25 Kogler G, Callejas J, Hakenberg P, Enczmann J, Adams O, Däubener W, Krempe C, Göbel U, Somville T, Wernet P. Hematopoietic transplant potential of unrelated cord blood: critical issues. J Hematother 1996; 5: 105-16.
- 26 Solves P, Mirabet V, Planelles D, Blasco I, Perales A, Carbonell-Uberos F, Soler MA, Roig R. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking:comparative study. Transfusion 2005; 45: 867-73.
- 27 Pegg DE. Mechanisms of freezing damage. Symp Soc Exp Biol 1987; 41: 363-78.
- 28 Solves P, Mirabet V, Blanquer A, Delgado-Rosas F, Planelles D, Andrade M, Carbonell-Uberos F, Soler MA, Roig R. A new automatic device for routine cord blood banking: critical analysis of different volume reduction methodologies. Cytotherapy 2009; 11: 1101-7.
- 29 Broxmeyer HE, Srour EF, Hangoc G, Cooper S. Anderson SA and Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003; 100: 645-50.
- 30 Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing:a comparison of postthaw and postwash samples. Transfusion 2005; 45: 1909-16.
- 31 Flores AI, McKenna DH, Montalbán MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion 2009; 49: 636-47.
Citing Literature
